Activation of an S6 kinase from rat astroglial cells by cAMP  by Pierre, Michel et al.
Volume 228, number 2, 219-222 FBB 05568 February 1988 
Activation of an S6 kinase from rat astroglial cells by CAMP 
Michel Pierre, Jean-Michel Gavaret, Carole Matricon, Martine Pomerance, Claude Jacquemin 
and Danikle Toru-Delbauffe 
Unit6 de Recherche sur la Glande Thyroiae et la Rkgulation Hormonale, INSERM Unitt! 96, 78, rue du Gkntral Leclerc, 
94275 Le Kremlin-BicCtre, France 
Received 9December 1987 
Forskolin and isoproterenol, agonists of adenylate cyclase activity, and dibutyryl cyclic AMP, stimulated an S6 kinase 
activity in astroglial cells. This activity was insensitive to the thermostable inhibitor of cyclic AMP-dependent protein 
kinase and had the same behaviour on a DEAE-Sephacel column as the mitogen stimulated S6 kinase. These observations 
support the idea that the cyclic AMP cascade, as well as various growth factors, can activate S6 kinase. 
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1. INTRODUCTION 
The small ribosomal subunit protein, S6, is the 
major ribosomal protein phosphorylated in vivo 
[ 1). S6 is rapidly phosphorylated on several serine 
residues in cells stimulated by a variety of growth 
factors or TPA and in cells transformed by on- 
cogenes coding for tyrosine kinases. In recent years 
it has been shown that this phosphorylation is 
probably catalyzed by specific protein kinases, the 
S6 kinases. These enzymes are activated in 3T3 rat 
cells by EGF [2], in Swiss 3T3 cells by FGF [3], in 
3T3Ll cells by insulin and TPA [4], in chicken 
primary fibroblasts by TPA or by cell transforma- 
tion with retrovirus carrying the sarc oncogene 
[5,6], in Xenopus oocytes by insulin [7], in primary 
astroglial cells by insulin, IGFl and TPA [8], and 
in PC12 cells by NGF [9]. Except for FGF and 
NGF, for which the mechanism of action is less 
well documented, it is generally believed that the 
first activation step is the stimulation of protein 
kinase C or a tyrosine kinase. The requirement for 
protein phosphatase inhibitors to maintain S6 
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kinase activation also suggests that activated forms 
of these enzymes are phosphorylated [lo]. 
As cyclic AMP (CAMP) is the activator of a class 
of protein kinases and as many workers have 
reported that it modulates cell growth [11,12] we 
have examined its possible role in the activation 
pathway of S6 kinases using agents known to in- 
crease the level of intracellular CAMP, forskolin 
and isoproterenol, or the CAMP derivative, 
dibutyryl CAMP.’ These substances were used on 
astroglial cells in the presence or absence of insulin 
which increases cell multiplication [ 131, S6 kinase 
activity [8] and, in the presence of thyroid hor- 
mone, affects cell morphology [14]. 
The present results show that the treatment of 
these cells with CAMP promoting agents enhanced 
the activity of an S6 kinase resembling. the 
mitogen-stimulated kinase. 
:2. MATERIALS AND METHODS 
2.1. Materials 
Pure porcine insulin was obtained from Novo, forskolin, 
isoproterenol and N,O;dibutyryladenosine 3 ’ ,5 ’ -cyclic 
monophosphate (dbcAMP) were purchased from Sigma. 
2.2. Cell culture and cell extraction 
Astroglial cells were obtained from the cerebral hemispheres 
of Zday-old Sprague Dawley rats, grown to confluence (about 
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14 days) in DMEM (Dulbecco’s modified Eagle’s medium) con- 
taining 10% fetal calf serum and then transferred into chemical- 
ly defined medium as described [8]. 48 h prior to the 
experiment, the culture medium was deprived of insulin. The 
test reagents were added for various times, the culture medium 
was removed and the cells were rapidly rinsed with 3 ml/dish of 
80 mM&glycerophosphate, pH 7.4,20 mM EGTA and 15 mM 
MgCls (buffer A). All subsequent steps were performed at 4°C. 
The cells were scraped off into 0.3 ml/dish of buffer A contain- 
ing 1 mM phenylmethylsulfonyl fluoride, 50 fig/ml aprotinin, 
4 pg/ml leupeptin, 4 /g/ml antipain, 1 pg/ml trypsin inhibitor, 
1 mM benzamidine and 0.1 mM N-cu-p-tosyl-L-lysine 
chloromethyl ketone, broken in this buffer by sonication for 3 s 
and centrifuged at 100000 x g for 1 h. The resulting super- 
natants were stored at -80°C. 
2.3. Protein kinase assays 
S6 kinase activity was measured by adding aliquots of the 
supernatants (-10 fig protein) to a solution (final volume = 
50~1) containing 20 mM Hepes, pH 7.1, 3 mM MgClz, 2 mM 
dithiothreitol, lo-25 gg 40 S ribosomal protein or histone H2b 
(1 mg/ml) and 50cM [y-3ZP]ATP (-l-2&i/nmol). 40 S 
ribosomal subunits were isolated from rat liver according to 
Martin and Wool [15]. All subsequent steps were as described 
in [8]. 
2.4. Chromatography on DEAE-Sephacel 
The supernatants of untreated and 45 min treated cells by 
dbcAMP, forskolin or isoproterenol were dialyzed for 2 h 
against 30 mM ,f?-glycerophosphate, pH 7.4, 5 mM MgClz, 
2 mM EGTA, 2 mM dithiothreitol, 0.1 mM phenylmethylsul- 
fonyl fluoride. They were then treated for 30 min with 5 /IM 
CAMP and applied to the DEAE-Sephacel column (3 ml) 
equilibrated with 20 mM Tris-HCI, pH 7.4, 5 mM MgClz, 
2 mM EGTA, 2 mM dithiothreitol (buffer B) containing 
25 mM NaCl. The columns were washed with 15 ml of this buf- 
fer and proteins were eluted with a 60 ml linear gradient from 
25 to 350 ml NaCl in buffer B. Fractions (1 ml) were collected 
and S6 kinase activity was measured in each fraction. 
3. RESULTS AND DISCUSSION 
The astroglial cells were maintained in chemical- 
ly defined medium as described in section 2. 
In the first experiment, the cells were treated for 
various times with 10m3 M dbcAMP, lo-’ M for- 
skolin or 10e6 M isoproterenol in the presence or 
absence of insulin. Fig.1 shows the in vitro ‘*P- 
incorporation into S6 catalyzed by the cytosols of 
these cells. In the absence of insulin, dbcAMP, 
forskolin and isoproterenol promoted a time- 
dependent increase in S6 phosphorylation. The 
greatest effect was obtained with dbcAMP, which 
increased intracellular CAMP content more than 
forskolin and isoproterenol [ 161. Both these latter 
agents produced a similar effect on CAMP level. 
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Fig. 1. Time course of the 32P incorporation into S6 by cytosols 
of cells treated with (A) dbcAMP (lo-’ M), (B) forskolin 
(lo-’ M) and (C) isoproterenol (10m6 M) in the absence 
(m) or presence (o--o) of insulin (10e6 M). The three 
agents were added to the culture medium at 5, 15, 30 and 
45 min prior ? T the end of the experiments; insulin was present 
throughout he 45 min. 
The presence of insulin enhanced the effects of 
dbcAMP and isoproterenol on S6 phosphoryla- 
tion, whereas it exerted a biphasic effect when add- 
ed with forskolin. A near maximal stimulation was 
reached at 5 min, but at 45 min there was no in- 
crease over the effect of forskolin alone, sug- 
gesting a complex relationship between the 
transduction mechanisms of forskolin and insulin. 
This observation may be compared to the results 
obtained by Stadtmauer and Rosen [17] who 
observed that forskolin treatment reduced the ac- 
tivity of the insulin receptor-tyrosine kinase in IM9 
cells. These authors considered that this effect of 
forskolin was due to an increase in intracellular 
CAMP. However, this is unlikely to be so for S6 
kinase in astroglial cells, since dbcAMP and 
isoproterenol, which also increase the CAMP con- 
tent, act additively in the presence of insulin. 
The increased 32P-incorporation into S6 de- 
scribed here, could be due either to the CAMP- 
dependent protein kinase (CAMP-PK), to the 
mitogen-stimulated S6 kinase or to another 
unidentified, S6 kinase. 
The following experiments were carried out to 
distinguish between these possibilities. 
First, S6 phosphorylation was performed in the 
presence or absence of the protein inhibitor of 
CAMP-PK, with cytosols from cells treated for 
45 min, with dbcAMP, forskolin or isoproterenol, 
with or without insulin. Fig.2A shows that the 32P 
incorporation into S6 with cytosols from un- 
treated, forskolin- and isoproterenol-treated cells 
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Fig.2. Cyclic AMP-dependent protein kinase activity in the 
supernatants of cells treated for 45 min with dbcAMP 
(10m3 M), forskolin (lo-’ M) and isoproterenol (10m6 M) in the 
presence or absence of insulin (10m6 M). “P incorporation into 
S6 (A) and histone H2b (1 mg/ml) (B) was determined without 
addition of CAMP. (m) Presence or (D and Ll) absence of 
thermostable CAMP-PK inhibitor (to inhibit 15 units of 
CAMP-PK). 
was not affected by the presence of the inhibitor. 
This indicates that activity measured with these ex- 
tracts is that of an S6 kinase, which is different 
from CAMP-PK. In contrast, 32P incorporation in- 
to S6 by cytosol from dbcAMP-treated cells was 
partly (30-5O(rlo) blocked by a maximal effective 
concentration of the CAMP-PK inhibitor, in- 
dicating that the activity measured in the cytosol 
from dbcAMP-treated cells was due, in our test 
conditions, to both CAMP-PK and S6 kinase. The 
difference between the effects of cytosols from 
dbcAMP-treated cells and those from forskolin- or 
isoproterenol-treated cells might be due to the very 
high level of CAMP derivative that might be con- 
centrated enough in the test tube to keep the 
CAMP-PK in its dissociated form. These results 
were confirmed by assaying in the absence of in- 
hibitor and of added CAMP, protein kinase ac- 
tivities of the different cytosols on histone H2b, 
which is a good phosphate acceptor for CAMP-PK. 
The ‘*P incorporation into this protein by cytosol 
of forskolin- and isoproterenol-treated cells was 
similar to that obtained with control extract 
(fig.2B), showing the absence of free catalytic 
subunit of CAMP-PK. As expected, only 32P incor- 
poration catalyzed by the cytosol from dbcAMP- 
treated cells was significantly increased indicating 
the presence of free catalytic subunit. Fig.2A con- 
firms the additivity of the insulin and the 
isoproterenol effects and the absence of additivity 
of the insulin and the forskolin effects. Fig.2B 
shows the absence of effect of insulin on CAMP- 
PK activity, measured on its specific substrate 
histone H2b. 
Secondly, to verify that increases in ‘*P incor- 
poration into S6 promoted by dbcAMP, forskolin 
and isoproterenol were effectively due to the ac- 
tivation of the mitogen-stimulated S6 kinase, cells 
deprived of insulin 48 h prior to the experiment 
were challenged for 45 min with each of the three 
agents. The cytosols from control and treated cells 
were chromatographed on DEAE-Sephacel col- 
umns. The S6 kinase activities obtained (fig.3) had 
the same behaviour as the mitogen-stimulated S6 
kinase (submitted). This enzyme was retained on 
the column and was eluted at 0.15 M with a linear 
Fraction number 
Fig.3. Chromatography on DEAE-Sephacel of S6 kinase 
activity unstimulated (M) and stimulated (o--o) by 
treatment of cells with (A) dbcAMP (10e3 M), (B) forskolin 
(10T5 M) and (C) isoproterenol (low6 M). 
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gradient of NaCl. The amount of S6 kinase activity 
eluted at 0.15 M NaCl was low, though variable, in 
control extracts and higher in the other extracts. 
CAMP-PK was dissociated before chromatography 
to avoid binding of its catalytic subunit to the 
resin, and thus prevent its activity interfering with 
that of S6 kinase. 
scribed in this report is rather paradoxical. If 
CAMP has this effect in a variety of cells, then, at 
the same time as S6 kinase is activated, the CAMP- 
PK may act on other protein targets to inhibit cell 
multiplication. 
These observations strongly suggest hat treat- 
ment of astroglial cells with agents which increase 
intracellular CAMP content activated an S6 kinase 
resembling the mitogen-stimulated kinase. How- 
ever, as the activated form(s) of the S6 kinase ap- 
pear(s) difficult to purify, it is not yet possible to 
provide absolute proof of their identity. 
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